These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1747 related articles for article (PubMed ID: 24813197)

  • 21. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
    Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lean mass and insulin resistance in women with polycystic ovary syndrome.
    Comerford KB; Almario RU; Kim K; Karakas SE
    Metabolism; 2012 Sep; 61(9):1256-60. PubMed ID: 22424820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Möller R; Horejsi R; Giuliani A; Kopera D; Schweighofer N; Groselj-Strele A; Pieber TR; Obermayer-Pietsch B
    Wien Klin Wochenschr; 2009; 121(7-8):262-9. PubMed ID: 19562283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
    Dobbie LJ; Pittam B; Zhao SS; Alam U; Hydes TJ; Barber TM; Cuthbertson DJ
    Hum Reprod; 2023 Jun; 38(6):1168-1182. PubMed ID: 37015099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
    Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
    Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    Hum Reprod; 2012 Dec; 27(12):3560-8. PubMed ID: 22940766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
    Cassar S; Misso ML; Hopkins WG; Shaw CS; Teede HJ; Stepto NK
    Hum Reprod; 2016 Nov; 31(11):2619-2631. PubMed ID: 27907900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting energy expenditure in women with polycystic ovary syndrome.
    Tosi F; Rosmini F; Gremes V; Lucarini F; Zandonà M; Zanolin ME; Fiers T; Kaufman JM; Moghetti P
    Hum Reprod; 2024 Aug; 39(8):1794-1803. PubMed ID: 38867472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome.
    Wen X; Wang L; Bai E
    Front Endocrinol (Lausanne); 2024; 15():1370578. PubMed ID: 39109080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.